Michael Sweeney



Michael Sweeney is an associate with Foley & Lardner LLP, where he is a member of the firm’s Chemical, Biotechnology & Pharmaceutical Practice. Michael’s practice includes patent counseling and procurement in the biomedical engineering and biological arts. He specializes in a diverse range of matters, including drafting and prosecuting patents, providing opinions for patentability, invalidity, and freedom-to-operate, and developing and executing strategies for intellectual property portfolios. Michael assists clients with technologies in a broad array of life science fields, including medical devices, microbiology, immunology, CRISPR and bioengineering, genetics and genomics, diagnostics, nanobiotechnology, and computational biology.

Michael assists in the negotiation of technology and commercial agreements including patent and software licenses, technology transfer, manufacturing and supply of drug conjugates, collaboration and joint venture agreements for the biotechnology and life science industries. Michael has also provided litigation support on patent matters relating to dental implants and medical devices.

Michael began working at Foley as a summer associate in 2016. Prior to that, he consulted part-time with startups regarding their intellectual property management while attending school for his engineering degree.


Michael earned his law degree from Northwestern University School of Law (J.D., 2012), where he was a published note and comment editor for the Journal of Technology and Intellectual Property. After law school, he obtained his master’s degree in biomedical engineering from Columbia University (M.S., 2017).

Michael earned his bachelor’s degree from the University of California, Santa Barbara (B.A., 2006), where he majored in law and society, and minored in English.


Michael is admitted to practice in California. He is also registered to practice before the United States Patent and Trademark Office.


  • Co-author, “Agricultural Bioengineering and Food Manufacturing: Navigating the Regulatory Terrain,” Food Online (2018)
  • Co-author, “How the Fanapt Product Label Established Infringement of Personalized Treatment Claims,” National Law Review (2018)
  • Co-author, “Agricultural Bioengineering: The Shifting Landscape,” Feed & Grain (2018)
  • Author, “Correcting Bayh-Dole's Inefficiencies for the Taxpayer,” 10 NW. J. TECH. & INTELL. PROP. 295 (2012)